webinar register page

Radical cure of vivax malaria: can we do better?

A one-hour webinar with presentations and an expert discussion:

• Dr Rob Commons, Menzies School of Health Research, on 8AQ efficacy in clinical trials

• Dr Alison Roth, Walter Reed Army Institute of Research, on laboratory studies assessing hypnozoitocidal activity

• Dr James Watson, Oxford University Clinical Research Unit, on the reassessment of tafenoquine pharmacometrics

• Discussion chaired by Dr Chau Nguyen Hoang, Oxford University Clinical Research Unit, and Professor Sir Nicholas White, Mahidol Oxford Research Unit

About this event
Large individual patient data meta-analyses show that the dosing of the 8-aminoquinoline drugs primaquine and tafenoquine could be substantially improved. These analyses include the majority of all studied vivax malaria patients who received 8-aminoquinoline drugs over the last 20 years. Laboratory work confirms these findings and provides important new information on the mechanism of action of these essential medicines.

Feb 3, 2023 12:00 PM in London